| ADM |
Report |
Diluted Adj. EPS (Q2 2026) |
BEAT |
pred ~$1.55 vs. cons $1.44 |
MEDIUM |
| ADM |
Report |
Crushing Operating Profit (Q2 2026) |
BEAT |
pred ~$290M vs. cons $256M |
MEDIUM |
| ADM |
Report |
Carbohydrate Solutions Operating Profit (Q2 2026) |
BEAT |
pred ~$370M vs. cons $354M |
MEDIUM |
| ADM |
Guide |
FY2026 Adj. EPS (full year) |
LOWER |
guide midpoint ~$4.65 vs. cons $4.78 |
MEDIUM |
| ADM |
Guide |
Q3 2026 Segment Operating Profit (directional) |
LOWER |
directionally lower than Q2 vs. cons $1.19B |
MEDIUM |
| ADM |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
MEDIUM |
| ADM |
Return |
5-day cumulative residual |
-1.5% (FADE) |
FADE — beat gets sold as FY guide midpoint anchors below $4.78 consensus and Q3 estimates are trimmed |
MEDIUM |